Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib

D Liu, A Liu, J Peng, Y Hu, X Feng - European Journal of Medical …, 2015 - Springer
Background To evaluate the feasibility and security of complete remission (CR) of advanced
hepatocellular carcinoma (HCC) achieved with sorafenib treatment, and investigate the …

[HTML][HTML] Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment

SB Kim - Case Reports in Gastroenterology, 2021 - karger.com
There are only 13 cases of complete remission after sorafenib use in advanced
hepatocellular carcinoma (HCC) worldwide. We herein report a rarer case in which the …

Complete response of hepatocellular carcinoma with right atrium and pulmonary metastases treated by combined treatments (a possible treatment effect of natural …

DH Kim, E Cho, SB Cho, SK Choi, S Kim, J Yu, YI Koh… - Medicine, 2018 - journals.lww.com
Interventions: Multidisciplinary treatment including radiotherapy (RT), transarterial
chemoembolization (TACE), and sorafenib. During a follow-up evaluation computed …

Complete response to short‐term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases

N Nakano, T Kawaoka, H Aikata, F Honda… - Hepatology …, 2016 - Wiley Online Library
We report a 60‐year‐old male patient who developed extrahepatic metastases in bone,
peritoneum, and lymph nodes (confirmed by computed tomography and positron emission …

经肝动脉化疗栓塞术联合索拉非尼治疗晚期肝细胞癌完全缓解1 例报告

马菁璠, 陈刚, 刘洪 - 临床肝胆病杂志, 2016 - lcgdbzz.org
< 正> 据报道[1] 每年约有750 000 例肝癌新增病例, 且逐年递增, 其中80% 85%
的肝癌患者被确诊时已丧失手术机会. 不能手术的患者, 可采用多种局部治疗方法 …

[引用][C] 抗肿瘤靶向药物研究现状

权修权, 朴惠顺, 康琳, 尹学哲, 高钟镐 - 中国药理学通报, 2015

[引用][C] 原发性肝癌合并门静脉癌栓的治疗进展

张志明, 黄山 - 中国基层医药, 2015

[引用][C] 索拉非尼靶向治疗肝细胞肝癌的现状与进展

刘代忠, 刘爱祥, 彭俊平 - 广西医科大学学报, 2013

[引用][C] 索拉非尼治疗肝癌射频消融术后门静脉癌栓一例

唐哲, 胡洪涛, 万仁瑞, 李向阳, 任浩 - 腹部外科, 2016

[引用][C] 晚期肝癌索拉菲尼治疗完全缓解1 例报告

刘代忠, 刘爱祥, 彭俊平 - 肿瘤预防与治疗, 2013